AIBS 2015
AIBS 2015 was the second edition of the Survey. In addition to AIBS’ core questions, the 2015 edition of the Survey put an emphasis on international market development activities.
- Over 1,200 Australian businesses were surveyed, drawn from 19 industry sectors, 93 sub-sectors, and operating in 114 international markets;
- China (17%), the United States (16%) and New Zealand (8%) were the most important markets for respondents, by international revenue;
- The biggest barriers to doing businesses internationally were culture and/or local business practices (29%), payment issues (10%) and regulations that
favour local firms (9%);
- Over three-quarters of respondents placed significant emphasis on personally visiting overseas customers in order to develop and grow their international markets.
Country Reports
Industry Reports
Join Us
Become A Member
Eric Meppem,
Co-Founder & Commercial Director,
Pharmako Biotechnologies Pty Ltd
Member of the ECA
"Pharmako Biotechnologies were already exporting when we joined the ECA. We joined to assist our export strategies, and unashamedly to promote ourselves
through the Australian Export Awards. As a small business, third party recognition and industry membership assist when dealing with large
multinational businesses."
Featured Member
.png?Action=thumbnail&algorithm=fill_proportional&width=262)
Established in 1970, Mavlab Animal Health Pty Ltd is a Queensland based, family-owned, GMP licenced manufacturer of veterinary pharmaceuticals and pet care products. Mavlab has an extensive range of prescription and over the counter
products sold in a growing number of global markets. Contract manufacturing opportunities are also available.